tradingkey.logo

Teleflex Inc

TFX
查看詳細走勢圖
122.240USD
-0.050-0.04%
收盤 12/24, 16:00美東報價延遲15分鐘
5.40B總市值
虧損本益比TTM

Teleflex Inc

122.240
-0.050-0.04%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-0.04%

5天

-1.82%

1月

+6.57%

6月

+2.59%

今年開始到現在

-31.32%

1年

-31.04%

查看詳細走勢圖

TradingKey Teleflex Inc股票評分

單位: USD 更新時間: 2025-12-24

操作建議

Teleflex Inc當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名61/206位。機構持股佔比非常高,近一個月多位分析師給出公司評級為持有。最高目標價133.58。中期看,股價處於平穩狀態。近一個月,市場表現較強,技術面和基本面綜合得分較高,較強的走勢獲得基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Teleflex Inc評分

相關信息

行業排名
61 / 206
全市場排名
151 / 4562
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 14 分析師
持有
評級
133.579
目標均價
+11.48%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Teleflex Inc亮點

亮點風險
Teleflex Incorporated is a global provider of medical technologies. The Company offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. It primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.
高分紅
公司屬於高分紅公司,最新股息支付率90.56%
穩定分紅
公司5年內持續分紅,最新股息支付率90.56%
估值低估
公司最新PE估值-17.04,處於3年歷史低位
機構減倉
最新機構持股47.10M股,環比減少10.12%
ETHSX持倉
明星投資者ETHSX持倉,最新持倉343.00股

Teleflex Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Teleflex Inc簡介

Teleflex Incorporated is a global provider of medical technologies. The Company offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. It primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.
公司代碼TFX
公司Teleflex Inc
CEOKelly (Liam J)
網址https://www.teleflex.com/usa/en/#

常見問題

Teleflex Inc(TFX)的當前股價是多少?

Teleflex Inc(TFX)的當前股價是 122.240。

Teleflex Inc 的股票代碼是什麼?

Teleflex Inc的股票代碼是TFX。

Teleflex Inc股票的52週最高點是多少?

Teleflex Inc股票的52週最高點是185.940。

Teleflex Inc股票的52週最低點是多少?

Teleflex Inc股票的52週最低點是102.580。

Teleflex Inc的市值是多少?

Teleflex Inc的市值是5.40B。

Teleflex Inc的淨利潤是多少?

Teleflex Inc的淨利潤為69.67M。

現在Teleflex Inc(TFX)的股票是買入、持有還是賣出?

根據分析師評級,Teleflex Inc(TFX)的總體評級為持有,目標價格為133.579。

Teleflex Inc(TFX)股票的每股收益(EPS TTM)是多少

Teleflex Inc(TFX)股票的每股收益(EPS TTM)是-7.177。
KeyAI